SCHEMBL8210599

SCHEMBL8210599

Nc1ccc(N2C[C@H](CNC(=O)c3ccc(Cl)s3)CC2=O)cc1

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 20/20 0.55
▸ F2 P00734 3/20 0.55
▸ ABCB11 O95342 1/20 0.52
▸ ST14 Q9Y5Y6 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8245918 1.00 F10 (0.55) F10F2ABCB11ST14
SCHEMBL5642802 0.90 F10 (0.52) F10F2ABCB11ST14
SCHEMBL5479123 0.88 F10 (0.71) F10F2ABCB11ST14
SCHEMBL8243982 0.87 F10 (0.56) F10F2ABCB11ST14
SCHEMBL5482932 0.87 F10 (0.72) F10F2ABCB11ST14
SCHEMBL4587228 0.87 F10 (0.67) F10F2ABCB11ST14
SCHEMBL8206823 0.87 F10 (0.51) F10F2ABCB11ST14
SCHEMBL8219680 0.87 F10 (0.67) F10F2ABCB11ST14
SCHEMBL5640924 0.86 F10 (0.61) F10F2
SCHEMBL13977416 0.85 F10 (0.74) F10F2ABCB11ST14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008052671-A2 COMBINATION THERAPY OF SUBSTITUTED OXAZOLIDINONES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-05-08 — — WO disclosed
WO-2007042146-A1 MICROANGIOPATHY TREATMENT AND PREVENTION BAYER HEALTHCARE AG (DE) 2007-04-19 — — WO disclosed
Send feedback